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Objective: t o a s s e s s t h e e f f i c a c y of benzathine p e n i c il l i n ( U P ) f o r t r e a t i n g presumedly pneumococcal a l v e o l a r lobar/segmental pneumonia(ALSP)as compared t o procaine p e n i c i l l i n ( P P ) , i n Belo Horizonte, Minas C e r a i s S t a t e . B r a z i l . Methods: c r i t e r i a i n c l u s i o n were a)2-12 y e a r s o l d , b ) c l i n i c a l and r a d i o l o g i c a l d i a g n o s i s oE ALSP.c)no p r i o r a n t i b i o t i c and d)no sev e r e concomitant disease.The BP and PP t r e a t m e n t s were randomized i n two groups and t h e regimens were one s i n g l e dose 01 BI' and seven days of PP.Efficacy was a s s e s s e d by c l i n i c a l and r a d i o l o g i c a l improvement i n t h e 7 t h and/or 14th day a f t e r admission.'L'he i n t e rp r e t a t i o n of c h e s t f i l m s were made i n a b l i n d n e s s f a s h i o n . S t a t i st i c a l a n a l y s i s included t h e F i s c h e r ' s Exact T e s t ( s i g n . l c v c l : . 0 5 ) . Results:116 p a t i e n t s had been included i n the study;63(54,3X)wcre a l l o c a t e d t o BP and 53(45,7%)to PP groups. 90,5% of the p .~t i e n t s i n t h e BP group and 94.3% i n t h e PP group presented c l i o i c n l and r a d i o l o g i c improvernents(p=.505). Conc1usions:a)BP treatment was a s e l l i c a c i o u s a s 1' 1' trcatnlcnt f o r ALSP i n t h i s study;b)due t o high morbidity and m o r t a l i t y of pncumonia i n the Third World.tl~e low c o s t and c x c e l l e n t cumpli:~nce o f B P , t h i s regimen may be an important a l t e r n a t i v e f o r i n t e r n a t i o n a l l y accepted PP regimen;c)more p r e c i s e e s t i m a t e s with improved pow e r w i l l be generated by higher numbers a s t h e study c o n t i n u e s . *supported by FINEP(Studies and P r o j e c t s Financing Agcncy),Urazil T h e r e is a sufficienl amount of data that TNF-alpha, the monokine r d u c e d by macro)h?ges after bacterial stimulation mi 1111 he a n import:tnt actor responsible o r trreverstble tlssue damnge durin hie septic shock. In a n attempt t o elucidate the ossihle function of ~~F -; h p h a in the pathomechanism of sepsis t i e aisesment of TNF-alplla ;tctivity in the blood of newborns with bacterial septicaemia was performed. A sample of 21 newbortls with se sis 13 with Staph.epi., 1 with Staph.aur., 7 with G(-) bacteria) was slu$ied.(A group of 22 infection-free tnf;tnts m:ttched by gestational age, birthweight and sex, were used a s a controls. TNF-alpha in the blood was determined by ELlSA method. For statistic analysis a nonarametric (Wilcoxon) test was used. ~auerl, Dept. W a t r . , Erasnus Univ R'dam, Sophia C h i l d r e n l s Hosp., R~~L~, JaJlssen Fharmac€Utica, ~i l b q~, t h e N e t h e r l a x i s . lh ircreasing use o f i n v a s i v e p r x c e d u r e s , a n t i b i o t i c and i m m m c a w i v e treatments has caused an increase in d d a l infections which has l e d to a seKch f o r new a n t i f u q a l drugs. I n our earlier studies (1) k e t O m~Z 0 l e ( k e t o ) , a n oral a n t i f u q a l agent, p m e d not to be useful in p r e t e n m . ' me atsorption o f k e t n w a s probably p r e v e n t e , also an oral a n t i f u r g a l agent w i t h h r o a d spectnrm a c t i v i t y an3 low toxicity, in preterm infants w i t h a p x t a m x p t i o~l a g e below 32 weks. 'I?mqh and peak sennn l e v e l s o f itra (R51211) and its m e t a b 3 l i t e (R63373) were measured i n 5 p r e t e n n infants 48h a f t e r i n i t i a w therapy w i t h a dose o f 5m3/kg o f itra i n hydroxypmpyl-heta-cyclcdextrin solution by HPLC-assay. 
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1 7 8 6 6 0 W e m l u d e that ( 2 ) i t r a is w e l l absorbed and reammxded levels are reached. No s i d e e f f e c t s of i t r a were seen. I t m y be a useful a n t i f u n g a l drug in p r e t e n n s , tut f u r t h e r shdies on e f f i c a c y and safety are needed. 
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The effects of cbz-leucine-tyrosine-chloromethylketone(zLYCK). an inhibitor of chymotrypsin, were investigated in the activation pathways of human neutrophil respiratory burst. At I0 pM zLYCK showed a parallel inhibition of superoxide productio~i Stimulated with the chemoattractant lormyl-methion$-leucyl phenylalanine (FMLP) and chymolrypsin-like activity of human neutrophils. By contrast superoxide production induced by phorbol mirystate acetate (PMA) was minimally affected by zLYCK. The known transduction pathways triggered by FMLP were analyzed. zLYCK did not anect either FMLP-induced cylosolic lree calcium transient, inositol 1.4.5 lriphosphate formation nor the PMA-induced phosphorylation of the 47 kD substrate of protein kinase c, zLYCK did not anect the activity of protein kinase c exlracted from neutrophds. The activity of the NADPH oxidase tested with active membranes from stimulated neutrophils or in a cell-free-system was no1 inhibited by zLYCK. We conclude that 1) zLYCK inhibits superoxide production through the inhibition of a chymotrypsin-like protease of the neutrophil 2) zLYCK inhibits FMLP-induced activation of NADPH oxidase through a pathway independent of PtdlnsP breakdwon and cylosolic free calcium 3) zLYCK may prove an useful pr&e for the characterization of its target protease in neutrophil activation. lmmunotherapy with serum obtained from immunized volunteers with Escherichia Coli J5 vaccine was shown to decrease the mortality from Gramnegative shock. We analyzed the effect of anti-J5 plasma on the course and mortality of severe infectious purpura. Patients with a clinical diagnosis of sepsis wiwth purpuric lesions were enrolled if they were in shock. They received either anti-JS plasma or control plasma. Before the administration of the plasma. 6 hours after and after 5 days of evolution, serum levels of anti-JS antibodies. tumor necrosis factor alpha (TNF), interleukin-6 (1L-6) and elastase-al-antiprotease complexes were determined. 73 patients were randomized, 40 in the anti-15 and 33 in the control group. Clinical and biological risk factors were similar in the two groups. However. T N F serum concentrations were 974t173pgfml versus 473+8Spg/ml. (p=0.023) and IL-6 serum concentrations were 129+45 versus 19tSng/rnl. (p=0.005) in the control group and in the treated group respectively. The duration of hypotension, of vasopressor therapy and of respiratory assistance and the occurrence of systemic complications were similar in the 2 groups. The mortality rate was 36 % ,in the control group and 25% in the treated group (p=0.317). (risk rat10:0.58;95% confidence interval:0.19-1.79). This trend disappeared after correction for imbalances at randomization using a logistic regression model. Anti-J5 plasma did not change the course and the mortality of severe infectious purpura in children.
